Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ming-Wen An

Showing results (11-20 of 30) with videos related to

Pageof 3
Sort By:
Computational and Mathematical Methods in Medicine|February 5, 2015
The direct assignment option as a modular design component: an example for the setting of two predefined subgroupsMing-Wen An, Xin Lu, Daniel J Sargent, et al.
Contemporary Clinical Trials Communications|August 25, 2021
Modeling tumor measurement data to predict overall survival (OS) in cancer clinical trialsFang-Shu Ou, Jun Tang, Ming-Wen An, et al.
Biometrics|September 11, 2007
Principal stratification designs to estimate input data missing due to deathConstantine E Frangakis, Donald B Rubin, Ming-Wen An, et al.
Contemporary Clinical Trials|April 29, 2014
Exploring the statistical and clinical impact of two interim analyses on the Phase II design with option for direct assignmentMing-Wen An, Sumithra J Mandrekar, Martin J Edelman, et al.
Biometrics|May 16, 2008
The need for double-sampling designs in survival studies: an application to monitor PEPFARMing-Wen An, Constantine E Frangakis, Beverly S Musick, et al.
JCO Precision Oncology|March 20, 2020
Discussion of Trial Designs for Biomarker Identification and Validation Through the Use of Case StudiesFang-Shu Ou, Ming-Wen An, Amy S Ruppert, et al.
Pediatrics|August 5, 2009
Evaluation of school-based smoking-cessation interventions for self-described adolescent smokersAlain Joffe, Clea McNeely, Elizabeth Colantuoni, et al.
Cancer Treatment Reviews|February 2, 2016
Clinical trial designs incorporating predictive biomarkersLindsay A Renfro, Himel Mallick, Ming-Wen An, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 12, 2014
Evaluation of alternate categorical tumor metrics and cut points for response categorization using the RECIST 1.1 data warehouseSumithra J Mandrekar, Ming-Wen An, Jeffrey Meyers, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 28, 2015
Clinical Utility of Metrics Based on Tumor Measurements in Phase II Trials to Predict Overall Survival Outcomes in Phase III Trials by Using Resampling MethodsMing-Wen An, Yu Han, Jeffrey P Meyers, et al.
Pageof 3

Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
Computational and Mathematical Methods in Medicine|February 5, 2015
The direct assignment option as a modular design component: an example for the setting of two predefined subgroupsMing-Wen An, Xin Lu, Daniel J Sargent, et al.
Contemporary Clinical Trials Communications|August 25, 2021
Modeling tumor measurement data to predict overall survival (OS) in cancer clinical trialsFang-Shu Ou, Jun Tang, Ming-Wen An, et al.
Biometrics|September 11, 2007
Principal stratification designs to estimate input data missing due to deathConstantine E Frangakis, Donald B Rubin, Ming-Wen An, et al.
Contemporary Clinical Trials|April 29, 2014
Exploring the statistical and clinical impact of two interim analyses on the Phase II design with option for direct assignmentMing-Wen An, Sumithra J Mandrekar, Martin J Edelman, et al.
Biometrics|May 16, 2008
The need for double-sampling designs in survival studies: an application to monitor PEPFARMing-Wen An, Constantine E Frangakis, Beverly S Musick, et al.
JCO Precision Oncology|March 20, 2020
Discussion of Trial Designs for Biomarker Identification and Validation Through the Use of Case StudiesFang-Shu Ou, Ming-Wen An, Amy S Ruppert, et al.
Pediatrics|August 5, 2009
Evaluation of school-based smoking-cessation interventions for self-described adolescent smokersAlain Joffe, Clea McNeely, Elizabeth Colantuoni, et al.
Cancer Treatment Reviews|February 2, 2016
Clinical trial designs incorporating predictive biomarkersLindsay A Renfro, Himel Mallick, Ming-Wen An, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 12, 2014
Evaluation of alternate categorical tumor metrics and cut points for response categorization using the RECIST 1.1 data warehouseSumithra J Mandrekar, Ming-Wen An, Jeffrey Meyers, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 28, 2015
Clinical Utility of Metrics Based on Tumor Measurements in Phase II Trials to Predict Overall Survival Outcomes in Phase III Trials by Using Resampling MethodsMing-Wen An, Yu Han, Jeffrey P Meyers, et al.
Pageof 3